LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 114.44%671.2M | 233.47%244.1M | 2,133.70%404.3M | -408.60%-154.3M | 3.15%177.1M | -55.03%313M | 131.65%73.2M | -89.21%18.1M | -42.92%50M | -58.02%171.7M |
Net income from continuing operations | -28.58%430.3M | 132.07%128.8M | -25.40%126.3M | -85.69%28.1M | -18.91%147.1M | -39.59%602.5M | -84.29%55.5M | -17.41%169.3M | -2.53%196.3M | -23.69%181.4M |
Operating gains losses | 36.30%-8.6M | --0 | -242.42%-4.7M | ---- | ---- | 93.48%-13.5M | --0 | --3.3M | ---- | ---- |
Depreciation and amortization | 10.78%75M | 12.28%19.2M | 10.53%18.9M | 8.33%18.2M | 11.98%18.7M | -1.88%67.7M | 11.04%17.1M | 0.00%17.1M | -7.18%16.8M | -9.24%16.7M |
Deferred tax | 32.75%52.7M | 40.27%52.6M | --200K | --0 | -103.57%-100K | -73.27%39.7M | -75.47%37.5M | --0 | 73.91%-600K | 800.00%2.8M |
Other non cash items | 39.36%83.2M | -2.34%16.7M | 45.75%22.3M | 47.41%19.9M | 76.09%24.3M | 33.86%59.7M | 28.57%17.1M | 44.34%15.3M | 37.76%13.5M | 26.61%13.8M |
Change In working capital | 76.45%-137M | 104.17%7.3M | 224.55%236.9M | -113.29%-357.9M | 51.96%-23.3M | -48.77%-581.7M | 42.12%-175.2M | -164.17%-190.2M | 7.55%-167.8M | -129.36%-48.5M |
-Change in receivables | 61.15%-44.1M | 29.39%-88.9M | 59.89%-15.2M | 117.53%3.4M | -18.79%56.6M | -470.92%-113.5M | -122.05%-125.9M | -174.31%-37.9M | -908.33%-19.4M | 105.60%69.7M |
-Change in inventory | 60.01%-230.2M | 114.37%41.9M | 183.89%34.9M | -54.09%-322.5M | 146.55%15.5M | -109.73%-575.7M | 10.39%-291.5M | -1,123.53%-41.6M | -1,200.00%-209.3M | -147.37%-33.3M |
-Change in payables and accrued expense | -36.42%167.6M | -83.74%45.5M | 354.58%200.1M | -268.82%-57.4M | -172.54%-20.6M | 570.71%263.6M | 371.12%279.8M | -205.84%-78.6M | 149.93%34M | -79.86%28.4M |
-Change in other current assets | 88.53%-15.3M | 157.68%18.4M | 163.27%20.5M | -47.52%21.2M | 31.14%-75.4M | -84.51%-133.4M | -114.95%-31.9M | 66.25%-32.4M | 137.69%40.4M | -32.73%-109.5M |
-Change in other current liabilities | -1.87%-27.2M | -18.33%-7.1M | 12.82%-6.8M | 7.14%-6.5M | -15.25%-6.8M | -5.12%-26.7M | 1.64%-6M | -62.50%-7.8M | 6.67%-7M | 15.71%-5.9M |
-Change in other working capital | 205.00%12.2M | -933.33%-2.5M | -58.02%3.4M | 160.00%3.9M | 252.38%7.4M | -39.39%4M | 101.21%300K | 17.39%8.1M | -143.33%-6.5M | -77.89%2.1M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 114.44%671.2M | 233.61%244.2M | 2,133.70%404.3M | -408.80%-154.4M | 3.15%177.1M | -55.03%313M | 131.65%73.2M | -89.21%18.1M | -42.92%50M | -58.02%171.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 91.83%-137.2M | 90.24%-155M | 228.32%35.8M | 39.73%-4.4M | 75.36%-13.6M | -461.18%-1.68B | -785.37%-1.59B | 74.91%-27.9M | -106.47%-7.3M | -123.87%-55.2M |
Capital expenditure reported | -116.58%-308.2M | -103.80%-134.1M | -15.69%-41.3M | -55.08%-39.7M | -512.50%-93.1M | -31.88%-142.3M | -86.93%-65.8M | -7.53%-35.7M | -36.90%-25.6M | 26.92%-15.2M |
Net business purchase and sale | 113.04%191.6M | ---- | ---- | 38.76%42.6M | --102M | -311.05%-1.47B | ---- | ---- | --30.7M | --0 |
Net investment purchase and sale | 81.71%-15.2M | -13.51%-25.2M | 550.00%27.9M | 50.34%-7.3M | 73.50%-10.6M | 32.77%-83.1M | 59.86%-22.2M | 91.42%-6.2M | -458.54%-14.7M | -39,900.00%-40M |
Net other investing changes | -60.12%6.5M | -510.10%-187.3M | ---- | ---- | ---- | --16.3M | ---30.7M | 884.21%44.7M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 91.83%-137.2M | 90.24%-155M | 228.32%35.8M | 39.73%-4.4M | 75.36%-13.6M | -461.18%-1.68B | -785.37%-1.59B | 74.91%-27.9M | -106.47%-7.3M | -123.87%-55.2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -143.40%-510.3M | -105.27%-80.1M | -1,605.73%-446.9M | 175.18%196.9M | -227.64%-180.2M | 206.47%1.18B | 997.16%1.52B | -70.13%-26.2M | 31.92%-261.9M | 89.72%-55M |
Net issuance payments of debt | -121.78%-317.1M | -105.05%-79.1M | -1,276.15%-357.8M | 435.01%240.2M | -766.19%-120.4M | 280.05%1.46B | 2,016.50%1.57B | -71.05%-26M | 81.36%-71.7M | 95.75%-13.9M |
Net common stock issuance | 30.78%-193.2M | 97.90%-1M | -44,450.00%-89.1M | 77.23%-43.3M | -45.50%-59.8M | 5.45%-279.1M | 45.60%-47.6M | 0.00%-200K | ---190.2M | 80.19%-41.1M |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | -200.00%-1.2M | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -143.40%-510.3M | -105.27%-80.1M | -1,605.73%-446.9M | 175.18%196.9M | -227.64%-180.2M | 206.47%1.18B | 997.16%1.52B | -70.13%-26.2M | 31.92%-261.9M | 89.72%-55M |
Net cash flow | ||||||||||
Beginning cash position | -80.58%45.7M | 44.95%60.3M | -13.29%67.2M | -90.23%29M | -80.58%45.7M | 31.53%235.3M | -70.56%41.6M | -22.58%77.5M | 4.40%296.8M | 31.53%235.3M |
Current changes in cash | 112.50%23.7M | 121.95%9.1M | 80.78%-6.9M | 117.42%38.2M | -127.15%-16.7M | -436.17%-189.6M | -95.64%4.1M | -187.14%-35.9M | -19.06%-219.3M | -41.65%61.5M |
End cash Position | 51.86%69.4M | 51.86%69.4M | 44.95%60.3M | -13.29%67.2M | -90.23%29M | -80.58%45.7M | -80.58%45.7M | -70.56%41.6M | -22.58%77.5M | 4.40%296.8M |
Free cash flow | 112.65%363M | 1,387.84%110.1M | 2,162.50%363M | -895.49%-194.1M | -46.33%84M | -70.97%170.7M | 305.56%7.4M | -113.08%-17.6M | -64.59%24.4M | -59.69%156.5M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Adverse Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |